What Rheumatologists Need to Know About Cancer Risk in Rheumatoid Arthritis
An overview for rheumatologists on the management of cancer risk in patients with rheumatoid arthritis.
All articles by Inga Back, MPH
2019 EULAR/ACR Criteria More Sensitive, Similarly Specific to 1997 ACR Criteria for Classification of Youth With SLE
Researchers compared the diagnostic usefulness of the 2019 ACR/EULAR classification criteria to that of the 1997 ACR classification criteria for SLE in children and young adults.
AMARA Study: Results Mixed for Rituximab Plus Leflunomide in Patients With RA
In the AMARA study, the researchers assessed the safety and efficacy of rituximab plus leflunomide in patients with rheumatoid arthritis.
Pegloticase Immunogenicity Reduced With Concomitant Mycophenolate Mofetil Use in Refractory Gout
Researchers evaluated the effect of mycophenolate mofetil on the efficacy of pegloticase in patients with refractory gout.
Clinician Q&A: Can Immunomodulators Improve the Effect of Pegloticase in Uncontrolled Gout?
Robert T. Keenan, MD, discusses the role of co-treatment with immunomodulators and pegloticase in patients with uncontrolled gout.
No Significant Differences With Mavrilimumab vs Placebo in Outcomes of Patients With Severe COVID-19 Pneumonia, Hyperinflammation
Researchers evaluated the effect of mavrilimumab on the outcomes of patients with COVID-19 pneumonia and systemic hyperinflammation.
ASBMR, AACE, NOF Develop Joint Guidance on COVID-19 Vaccination and Osteoporosis Management
ASBMR, AACE, Endocrine Society, ECTS, IOF, and NOF developed guidance on COVID-19 vaccination and osteoporosis management.
Higher Prevalence of Early Discontinuation of Breastfeeding in Women With SLE vs General Population
Researchers assessed breastfeeding frequency, duration, and associated factors in women with systemic lupus erythematosus.
ASDAS Plus BASDAI Score May Better Predict Anti-TNF Treatment Efficacy in Ankylosing Spondylitis
Researchers assessed the prevalence of high disease activity, measured using ASDAS, in patients with ankylosing spondylitis with low BASDAI scores after anti-TNF treatment.
Past or Current Smoking Predicts End-Organ Damage in Systemic Lupus Erythematosus
Researchers compared the association of smoking history and pack-year exposure with rate of end-organ damage in systemic lupus erythematosus.
-
Loading...
-
Loading...
Next post in Systemic Lupus Erythematosus
